Scientific Abstracts - NASPGHAN
Results: In 2015, 85 patients began anti-TNF therapy ... This format allows for fellow tracking and test- ... [66%], UC: 19/37, [51%]) or mesalazine (CD: 87/96 [90?%], UC: 31/37, [84%]) ... higher sensitivity and specificity (63% and 91%, respectively) than anti-Saccharomyces cerevisiae antibodies, ASCA (47%. Télécharger Scientific Abstracts - NASPGHAN pdf
